REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING, PHILADELPHIA PA, APRIL 26-MAY 3, 2014 – A new phase II study reports that a novel dry-powder formulation of inhaled levodopa, CVT-301, may be useful for rapid improvement in motor function during Off periods (Freed et al. AAN 2014; abstract S7.007). Read More

REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING, PHILADELPHIA PA, APRIL 26-MAY 3, 2014 – Preliminary results are available for two novel MS therapies that are currently in development. Read More

REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING, PHILADELPHIA PA, APRIL 26-MAY 3, 2014 – There is an increasing body of evidence suggesting that neurofilament (NFL) protein is a useful biomarker of axonal injury. The latest study examined the prognostic value of NFL in survivors of cardiac arrest (Rosen et al. AAN 2014; abstract P1.101). Read More

REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING, PHILADELPHIA PA, APRIL 26-MAY 3, 2014 – Postdural puncture headache was first described over a century ago by Dr. August Bier, who pioneered spinal anesthesia (Bier A. Dt Zeitschr Chirung 1899;51:361-369). In Bier’s case, the procedure went terribly awry and his headache required bed rest for nine days. Read More